World-class
Scientific Advisory

Work with Richmond Pharmacology and trust your experience will be personal and truly strategic.

Dr Ulrike Lorch, MD FRCA FFPM
Medical Director

Dr Ulrike Lorch is a Co-Founder and Medical Director of Richmond Pharmacology. She holds Specialist Accreditation in Pharmaceutical Medicine and is a Fellow of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians (UK) and a Fellow of the Royal College of Anaesthetists (UK). Dr Lorch is Educational Supervisor for physicians participating in Pharmaceutical Medicine Specialist Training. She is a member of the Education Committee and a member of the Board of Examiners of the Faculty of Pharmaceutical Medicine.

Dr Lorch has more than 10 years experience in conducting Early Phase clinical research. She has been Principal Investigator in more than 120 studies at Richmond Pharmacology and Co-Investigator in more than 100 further studies. She has special expertise in adaptive study designs in early phase clinical trials, First-into-Human and other exploratory studies in healthy volunteers and patients of all ages, ethnic comparison, cardiac safety (including TQT), pain and gastrointestinal pH monitoring studies.

Jointly with her colleagues at Richmond Pharmacology she was instrumental in obtaining Standard and Supplementary MHRA Phase I Accreditation for the two Richmond Pharmacology research units. As one of the Principal Investigators at Richmond Pharmacology she is accredited to conduct all types of Phase I studies, including those that -due to potential risks- require review by the Expert Advisory Group in addition to the standard review by the MHRA.

Dr Lorch is a member of the British Association of Pharmaceutical Physicians (BrAPP), a Committee member of the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI, UK), the Phase I Advisory Group (National Research Ethics Service, Health Research Authority, UK), the Japanese Society of Pharmacology and Therapeutics and the Arbeitsgemeinschaft fur Angewandte Humanpharmakologie (AGAH, Germany).

The Royal College of Physicians and the Faculty of Pharmaceutical Medicine have published Dr Lorch's career profile on their websites. Two Fellows of the Faculty describe what they love about working in Pharmaceutical Medicine, how it differs from clinical medicine and what the challenges and benefits are of a career in the specialty. Please click here to view Dr Lorch's career profile.

Back to experts
r-gater-gater-gate

Latest news

Upcoming Event

The 41st Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

4 – 5 December 2020
The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development.
View event

Marking a milestone for gene editing

November 10, 2020
We are pleased to share that Richmond Pharmacology, in partnership with Intellia Therapeutics and the Royal Free Hospital, have treated the first patient in a landmark CRISPR/Cas9 clinical trial of NTLA-2001
Read more

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

October 20, 2020
Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)
Read more

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more